Pharmacologic evaluation of tolectin (tolmetin, mcn-2559) and mcn-2891, two anti-inflammatory agents.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000704:Analysis of Variance; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001168:Arthritis / Q000517:prevention & control*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001522:Behavior, Animal / Q000187:drug effects; D001565:Benzoates / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002351:Carrageenan; D004305:Dose-Response Relationship, Drug; D004487:Edema / Q000188:drug therapy*; D005260:Female; D005620:Freund's Adjuvant; D006321:Heart / Q000187:drug effects; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D010003:Osteoarthritis / Q000188:drug therapy; D010653:Phenylbutazone / Q000494:pharmacology; D011758:Pyrroles / Q000494:pharmacology / Q000627:therapeutic use*; D011809:Quinones / Q000037:antagonists & inhibitors; D051381:Rats; D012441:Saccharomyces cerevisiae; D014050:Toluene / Q000494:pharmacology / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D001565:Benzoates; D011758:Pyrroles; D011809:Quinones; C002895:McN 2891; D014050:Toluene; D002351:Carrageenan; D005620:Freund's Adjuvant; D010653:Phenylbutazone; D000109:Acetylcholine; D007213:Indomethacin